RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia

by Koschut, David, Ray, Debleena, Li, Zhenhua, Giarin, Emanuela, Groet, Jurgen, Alic, Ivan, Kham, Shirley Kow-Yin, Chng, Wee Joo, Ariffin, Hany Mohd, Weinstock, David M., Yeoh, Allen Eng-Juh, Basso, Giuseppe, Nizetic, Dean
Published 2021

Premature ocular aging features in childhood acute lymphoblastic leukemia survivors

by Chandrasekaran, Sudhashini, Ramli, Norlina, Jamaluddin Ahmad, Marium, Effendi, Irina, Amir, Nurul Najieha, Chow, Rhuen Chiou, Chee, Caroline Ka Lin, Azanan, Mohamad Shafiq, Abd Ghafar, Sayyidatul Syahirah, Ariffin, Hany Mohd, Kamalden, Tengku Ain Fathlun Tengku
Published 2021

Practical considerations for using RNA sequencing in management of B-lymphoblastic leukemia Malaysia-Singapore acute lymphoblastic leukemia 2020 implementation strategy

by Chin, Winnie Hui Ni, Li, Zhenhua, Jiang, Nan, Lim, Evelyn Huizi, Lim, Joshua Yew Suang, Lu, Yi, Chiew, Kean Hui, Kham, Shirley Kow Yin, Oh, Bernice Ling Zhi, Tan, Ah Moy, Ariffin, Hany Mohd, Yang, Jun J., Yeoh, Allen Eng-Juh
Published 2021

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

by Bornstein, Jacob, Roux, Surita, Petersen, Lone Kjeld, Huang, Li-Min, Dobson, Simon R., Pitisuttithum, Punnee, Diez-Domingo, Javier, Schilling, Andrea, Ariffin, Hany Mohd, Tytus, Richard, Rupp, Richard, Senders, Shelly, Engel, Eli, Ferris, Daron, Kim, Yae-Jean, Kim, Young Tae, Kurugol, Zafer, Bautista, Oliver, Nolan, Katrina M., Sankaranarayanan, Sandhya, Saah, Alfred, Luxembourg, Alain
Published 2021